Testing effectiveness (Phase 2)UnknownNCT03751176
What this trial is testing
Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal
Who this might be right for
Colorectal Cancer Metastatic
Grupo Espanol Multidisciplinario del Cancer Digestivo 31